Mabwell (shanghai) Bioscience Co., Ltd.

This study tests a new drug called 7MW4911 in 200 people with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. It is an early-stage trial, so the focus is on safety an…

This study tests whether combining two drugs, 9MW2821 and toripalimab, can safely improve outcomes for people with urothelial cancer (a type of bladder cancer) who are scheduled for surgery. About 90 adults will receive the treatment before and after their operation. The main goa…

This study tests two experimental drugs, 7MW3711 and JS207, given together (sometimes with chemo) to people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and see if the combination can shrink tumors or slow t…